Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | INTERLEUKIN 2 | authKW | 342386 | 6% | 18% | 622 |
2 | OK 432 | authKW | 167483 | 1% | 43% | 126 |
3 | CANCER IMMUNOLOGY IMMUNOTHERAPY | journal | 140321 | 4% | 10% | 447 |
4 | LYMPHOKINE ACTIVATED KILLER CELLS | authKW | 95836 | 1% | 34% | 89 |
5 | IMMUNOLOGY | WoSSC | 64663 | 38% | 1% | 3880 |
6 | LAK CELLS | authKW | 62128 | 1% | 36% | 55 |
7 | TUMOR INFILTRATING LYMPHOCYTES | authKW | 55982 | 1% | 15% | 120 |
8 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | journal | 54169 | 1% | 19% | 92 |
9 | ONCOLOGY | WoSSC | 51515 | 38% | 0% | 3802 |
10 | CELLULAR IMMUNOLOGY | journal | 47493 | 3% | 4% | 347 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Immunology | 64663 | 38% | 1% | 3880 |
2 | Oncology | 51515 | 38% | 0% | 3802 |
3 | Medicine, Research & Experimental | 5278 | 10% | 0% | 972 |
4 | Otorhinolaryngology | 1100 | 3% | 0% | 263 |
5 | Cell Biology | 1077 | 7% | 0% | 741 |
6 | Hematology | 840 | 4% | 0% | 362 |
7 | Pathology | 533 | 3% | 0% | 274 |
8 | Surgery | 497 | 6% | 0% | 616 |
9 | Urology & Nephrology | 434 | 3% | 0% | 270 |
10 | Biochemical Research Methods | 266 | 3% | 0% | 273 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ORAL BIOL ORAL MED | 13577 | 0% | 43% | 10 |
2 | BIOCHIM GEN GLYCOBIOL | 13021 | 0% | 83% | 5 |
3 | PROD LIFECYCLE MED INFORMAT | 12501 | 0% | 100% | 4 |
4 | RUPPERT | 12501 | 0% | 100% | 4 |
5 | PROD S | 11774 | 0% | 54% | 7 |
6 | TIMM | 11159 | 0% | 71% | 5 |
7 | UNITA OPERAT ASSISTENZIALE GINECOL ONCOL | 9376 | 0% | 100% | 3 |
8 | SERV 151Z2 | 8030 | 0% | 43% | 6 |
9 | IMMUNODIAG | 7140 | 0% | 57% | 4 |
10 | BOWYER ONCOL | 7031 | 0% | 75% | 3 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 140321 | 4% | 10% | 447 |
2 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 54169 | 1% | 19% | 92 |
3 | CELLULAR IMMUNOLOGY | 47493 | 3% | 4% | 347 |
4 | JOURNAL OF IMMUNOTHERAPY | 39342 | 1% | 9% | 147 |
5 | NATURAL IMMUNITY AND CELL GROWTH REGULATION | 28872 | 0% | 24% | 38 |
6 | BIOTHERAPY | 26493 | 0% | 17% | 50 |
7 | JOURNAL OF IMMUNOLOGY | 21842 | 6% | 1% | 625 |
8 | JOURNAL OF IMMUNOLOGICAL METHODS | 12941 | 2% | 2% | 203 |
9 | CANCER BIOTHERAPY | 11846 | 0% | 20% | 19 |
10 | NATURAL IMMUNITY | 10845 | 0% | 16% | 22 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |